India's pharma industry eyes $29B exports and $130B by 2030
Business
India's pharma industry is on track to hit almost $29 billion in exports by February 2026, even with all the market turbulence worldwide.
The big drivers? Formulations, vaccines, biologicals, and Ayush products.
Looking ahead, the sector is aiming high, with hopes to more than double its value to $130 billion by 2030.
India's pharma exports rose 5.6% Apr-Feb FY26 (April 2025-February 2026)
Despite pricing pressures and trade uncertainties, pharma exports grew 5.6% this financial year (April-February FY26 / April 2025-February 2026).
With strong demand for affordable medicines, India's role as a global supplier just keeps getting stronger.